Skip to main content

Consuelo Egla Diana Rabinovich, MD

Professor of Pediatrics
Chief, Division of Pediatric Rheumatology
Campus mail: 2301 Erwin Road, Chc T0909, Durham, NC 27710
Phone: (919) 684-6575
Email address: rabin001@mc.duke.edu

Therapeutic agents for treatment of Juvenile Arthritis.
Pediatric inflammatory eye disease (uveitis).
Pediatric localized scleroderma.

Education and Training

  • Fellow, Pediatric Rheumatology, Pediatrics, Duke University, 1988 - 1991
  • Resident, Pediatrics, Duke University, 1985 - 1988
  • M.D., Southern Illinois University, 1985

Selected Grants and Awards

Publications

Henderson, Lauren A., David Zurakowski, Sheila T. Angeles-Han, Andrew Lasky, C Egla Rabinovich, Mindy S. Lo, and Mindy S. Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry  Investigators. “Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.” Pediatr Rheumatol Online J 14, no. 1 (February 16, 2016): 9. https://doi.org/10.1186/s12969-016-0069-5.

Full Text

Elahi, Shan, Alison Homstad, Himani Vaidya, Jennifer Stout, Gentzon Hall, Guanghong Wu, Peter Conlon, et al. “Rare variants in tenascin genes in a cohort of children with primary vesicoureteric reflux.” Pediatr Nephrol 31, no. 2 (February 2016): 247–53. https://doi.org/10.1007/s00467-015-3203-6.

Full Text

Balevic, Stephen J., and C Egla Rabinovich. “Profile of adalimumab and its potential in the treatment of uveitis.” Drug Des Devel Ther 10 (2016): 2997–3003. https://doi.org/10.2147/DDDT.S94188.

Full Text

Ali, Joseph, Joseph E. Andrews, Carol P. Somkin, and C Egla Rabinovich. “Harms, benefits, and the nature of interventions in pragmatic clinical trials.” Clin Trials 12, no. 5 (October 2015): 467–75. https://doi.org/10.1177/1740774515597686.

Full Text

Lerman, Melissa A., and C Egla Rabinovich. “The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.” Paediatr Drugs 17, no. 4 (August 2015): 283–301. https://doi.org/10.1007/s40272-015-0128-2.

Full Text

Ringold, Sarah, Audrey Hendrickson, Leslie Abramson, Timothy Beukelman, Peter R. Blier, John Bohnsack, Elizabeth C. Chalom, et al. “Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.” Arthritis Care Res (Hoboken) 67, no. 4 (April 2015): 529–37. https://doi.org/10.1002/acr.22487.

Full Text

Bryan, Angela R., and C Egla Rabinovich. “Enthesitis-related arthritis: time to re-define?” Curr Rheumatol Rep 16, no. 12 (December 2014): 466. https://doi.org/10.1007/s11926-014-0466-z.

Full Text

Kalampokis, Ioannis, and C Egla Rabinovich. “Successful management of refractory pediatric-onset complex aphthosis with lenalidomide.” J Clin Rheumatol 20, no. 4 (June 2014): 221–23. https://doi.org/10.1097/RHU.0000000000000100.

Full Text

Hashkes, Philip J., Mara L. Becker, David A. Cabral, Ronald M. Laxer, Amy S. Paller, C Egla Rabinovich, Dan Turner, and Francesco Zulian. “Methotrexate: new uses for an old drug.” J Pediatr 164, no. 2 (February 2014): 231–36. https://doi.org/10.1016/j.jpeds.2013.10.029.

Full Text

Robinson, Angela Byun, Vin Tangpricha, Eric Yow, Reut Gurion, Laura E. Schanberg, Grace A. McComsey, and Grace A. APPLE Investigators. “Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy.” Lupus Sci Med 1, no. 1 (2014): e000037. https://doi.org/10.1136/lupus-2014-000037.

Full Text

Pages